Burntide Gummies, a dietary supplement manufacturer based in Largo, Florida, issued a product information update on Thursday detailing its ingredient panel, supplement facts, and customer service contact information. The company stated that the materials are intended to provide consumers with a clear breakdown of the components in each gummy and a way to reach support with questions or concerns.
The release includes a standard disclaimer noting that these statements have not been evaluated by the Food and Drug Administration and that the product is not designed to diagnose, treat, cure, or prevent any disease.
Update Highlights Ingredient Transparency and Support Access
The 2026 update focuses on making the ingredient panel and supplement facts for Burntide Gummies more accessible to consumers. For individuals and families evaluating supplement choices, having this information laid out clearly can assist in determining whether the product meets their dietary needs.
The company also included customer service contact details in the update, though the release did not specify whether those contacts include phone, email, or other channels. Burntide did not announce any changes to the product formula itself; the update centers on improving the clarity and availability of existing information. No sales figures or distribution numbers were provided in the release.
The company has not indicated whether further updates are scheduled for later in 2026. The release also did not specify whether the update applies to international markets or is limited to U.S. customers.
The update arrives amid growing consumer scrutiny of supplement labels and manufacturer disclosures, particularly among communities that place a high value on transparency.
Regulatory Framework Shapes Supplement Market
Burntide Gummies operate within the broader dietary supplement category, which includes gummy-form vitamins and minerals. The gummy supplement segment grew out of the traditional vitamin and mineral supplement market that expanded through the late 1900s and early 2000s.
In the United States, dietary supplements are governed by the Dietary Supplement Health and Education Act of 1994, which legally distinguishes supplements from conventional foods and drugs. That law places labeling and safety responsibilities on manufacturers rather than requiring pre-market approval from the Food and Drug Administration. As a result, the FDA does not evaluate supplement claims before products are sold.
The standard disclaimer appearing in Burntide’s release — noting that statements have not been evaluated by the FDA and that the product is not intended to treat disease — is a routine part of such disclosures, issued by rule rather than voluntarily. The legal framework means that manufacturers bear primary responsibility for accurate labeling and ingredient disclosure, while consumers must rely on those labels when making purchasing decisions.
Consumer Implications and Local Context
For ordinary shoppers, having the ingredient panel and supplement facts presented prominently can reduce the time spent searching through fine print or locating customer service information when questions arise. The update does not change the product’s formulation but aims to make existing data more readily accessible. The company is based in Florida, and the release signals a commitment to keeping local consumers informed, though the geographic scope of the update remains unspecified.
Accessible supplement facts help reduce uncertainty about what consumers are ingesting, a factor that has grown in importance as more shoppers read labels before buying. The update does not indicate any new distribution plans or market expansions.
Burntide Gummies remain a dietary supplement, and the company has directed consumers to the newly released details for ingredient and supplement information. No further updates have been announced for the remainder of 2026.
